OPKO Health Share Holder Equity 2010-2024 | OPK

OPKO Health share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
OPKO Health Annual Share Holder Equity
(Millions of US $)
2023 $1,389
2022 $1,562
2021 $1,685
2020 $1,672
2019 $1,615
2018 $1,791
2017 $1,844
2016 $2,092
2015 $1,980
2014 $836
2013 $873
2012 $179
2011 $161
2010 $23
2009 $32
OPKO Health Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $1,403
2024-06-30 $1,395
2024-03-31 $1,253
2023-12-31 $1,389
2023-09-30 $1,445
2023-06-30 $1,535
2023-03-31 $1,552
2022-12-31 $1,562
2022-09-30 $1,629
2022-06-30 $1,719
2022-03-31 $1,615
2021-12-31 $1,685
2021-09-30 $1,766
2021-06-30 $1,743
2021-03-31 $1,697
2020-12-31 $1,672
2020-09-30 $1,624
2020-06-30 $1,588
2020-03-31 $1,549
2019-12-31 $1,615
2019-09-30 $1,642
2019-06-30 $1,709
2019-03-31 $1,763
2018-12-31 $1,791
2018-09-30 $1,789
2018-06-30 $1,810
2018-03-31 $1,823
2017-12-31 $1,844
2017-09-30 $2,089
2017-06-30 $2,107
2017-03-31 $2,107
2016-12-31 $2,092
2016-09-30 $2,105
2016-06-30 $2,016
2016-03-31 $1,998
2015-12-31 $1,980
2015-09-30 $1,969
2015-06-30 $827
2015-03-31 $813
2014-12-31 $836
2014-09-30 $887
2014-06-30 $913
2014-03-31 $831
2013-12-31 $873
2013-09-30 $868
2013-06-30 $312
2013-03-31 $320
2012-12-31 $179
2012-09-30 $146
2012-06-30 $152
2012-03-31 $155
2011-12-31 $161
2011-09-30 $102
2011-06-30 $111
2011-03-31 $124
2010-12-31 $23
2010-09-30 $20
2010-06-30 $50
2010-03-31 $56
2009-12-31 $32
2009-09-30 $64
2009-06-30 $39
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.051B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $200.449B 24.45
Intuitive Surgical (ISRG) United States $186.791B 97.66
Edwards Lifesciences (EW) United States $44.123B 28.02
Alcon (ALC) Switzerland $41.807B 27.97
IQVIA Holdings (IQV) United States $35.805B 19.73
IDEXX Laboratories (IDXX) United States $33.758B 39.76
DexCom (DXCM) United States $31.263B 47.08
Waters (WAT) United States $21.860B 32.32
STERIS (STE) Ireland $20.481B 23.58
SONOVA HOLDING (SONVY) Switzerland $19.736B 0.00
Hologic (HOLX) United States $16.260B 17.56
Fresenius Medical Care AG KGaA (FMS) Germany $13.386B 13.74
Sysmex ADR (SSMXY) Japan $11.751B 0.00
Globus Medical (GMED) United States $11.252B 28.49
Penumbra (PEN) United States $9.308B 91.18
Masimo (MASI) United States $9.076B 43.92
Glaukos (GKOS) United States $8.319B 0.00
Teleflex (TFX) United States $8.274B 13.20
Integer Holdings (ITGR) United States $4.484B 25.41
PROCEPT BioRobotics (PRCT) United States $4.236B 0.00
Inari Medical (NARI) United States $3.246B 0.00
Veracyte (VCYT) United States $3.169B 95.09
LivaNova (LIVN) United Kingdom $2.584B 14.92
Nihon Kohden (NHNKY) Japan $2.392B 18.17
Tandem Diabetes Care (TNDM) United States $2.358B 0.00
Elekta AB (EKTAY) Sweden $2.084B 18.74
TransMedics (TMDX) United States $2.071B 65.64
Integra LifeSciences Holdings (IART) United States $1.682B 8.79
RxSight (RXST) United States $1.357B 0.00
Alphatec Holdings (ATEC) United States $1.326B 0.00
Artivion (AORT) United States $1.194B 79.11
Pulse Biosciences (PLSE) United States $1.106B 0.00
Paragon 28 (FNA) United States $0.840B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.739B 12.56
Mesa Laboratories (MLAB) United States $0.717B 16.91
IRadimed (IRMD) United States $0.693B 37.43
AxoGen (AXGN) United States $0.688B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.666B 0.00
Semler Scientific (SMLR) United States $0.573B 30.14
SiBone (SIBN) United States $0.556B 0.00
OrthoPediatrics (KIDS) United States $0.542B 0.00
Pacific Biosciences Of California (PACB) United States $0.540B 0.00
Treace Medical Concepts (TMCI) United States $0.434B 0.00
ClearPoint Neuro (CLPT) United States $0.429B 0.00
Tactile Systems Technology (TCMD) United States $0.408B 22.08
AngioDynamics (ANGO) United States $0.361B 0.00
Delcath Systems (DCTH) United States $0.352B 0.00
NeuroPace (NPCE) United States $0.344B 0.00
CVRx (CVRX) United States $0.294B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Inogen (INGN) United States $0.202B 0.00
Accuray (ARAY) United States $0.186B 0.00
KORU Medical Systems (KRMD) United States $0.184B 0.00
Sight Sciences (SGHT) United States $0.181B 0.00
Nevro (NVRO) United States $0.142B 0.00
Atossa Genetics (ATOS) United States $0.121B 0.00
Sensus Healthcare (SRTS) United States $0.116B 12.46
Spectral Diagnostics (EDTXF) Canada $0.091B 0.00
LENSAR (LNSR) United States $0.089B 0.00
Monogram Orthopaedics (MGRM) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
InspireMD (NSPR) Israel $0.078B 0.00
908 Devices (MASS) United States $0.072B 0.00
Vicarious Surgical (RBOT) United States $0.071B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Covalon Technologies (CVALF) Canada $0.064B 0.00
WORK Medical Technology Group (WOK) China $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.046B 0.00
EnVVeno Medical (NVNO) United States $0.044B 0.00
Neuronetics (STIM) United States $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
Precision Optics (POCI) United States $0.033B 0.00
NexGel (NXGL) United States $0.032B 0.00
Accelerate Diagnostics (AXDX) United States $0.029B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
Biosig Technologies (BSGM) United States $0.023B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Baird Medical Investment Holdings (BDMD) $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.009B 0.00
T2 Biosystems (TTOO) United States $0.007B 0.00
PAVmed (PAVM) United States $0.006B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00